Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Reunion Industry Brief.
National Personal Chef Day Spotlights a $16.88B Industry Transforming Luxury Dining at Home
EIN Presswire
·
July 16, 2025
On National Personal Chef Day, a $16.88B industry redefines luxury platforms like Chef2Nite turn home dining into bespoke, unforgettable experiences. MIAMI , FL, UNITED STATES, July 16, 2025 /EINPresswire.com/ -- As Americans increasingly seek...
Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.
GlobeNewswire, Inc.
·
August 25, 2025
Saint Herblain (France), August 25, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the United States Food and Drug Administration (FDA) has suspended the license for IXCHIQ®, citing four...
Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities
GlobeNewswire, Inc.
·
April 26, 2025
Saint Herblain (France), April 26, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that France’s national public health agency, the Haute Autorité de Santé (HAS), has updated its recommendation...
Valneva Responds to French Government’s Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion
GlobeNewswire, Inc.
·
March 24, 2025
Saint Herblain (France), March 24, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it is responding to the chikungunya outbreak that is rapidly intensifying in France’s Island of La Réunion...
Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates
GlobeNewswire, Inc.
·
August 12, 2025
Total revenues of €97.6 million compared to €70.8 million in the first half of 2024 Cash and cash equivalents of €161.3 million at end of June 2025 Further clinical and regulatory progress 2025 financial outlook confirmed Saint-Herblain (France),...
EU Balance of Payments and International Investment Position statistical sources and methods - B.o.p. and i.i.p. e-book
ECB - European Central Bank
·
July 22, 2025
Introduction The European Central Bank (ECB), with the support of the European System of Central Bank’s (ESCB’s) Statistics Committee, compiles and publishes the balance of payments (b.o.p.) and the international investment position (i.i.p.) of...
Bloomin' Blinds of BuxMont Is 2025 Franchise Owner of the Year at National Awards Event
EIN Presswire
·
July 30, 2025
Bloomin’ Blinds of BuxMont earns top franchise honors and national sales awards at 2025 Bloomin’ Blinds Family Reunion and Pink Party. SOUTHAMPTON, PA, UNITED STATES, July 30, 2025 /EINPresswire.com/ -- At the 2025 Bloomin’ Blinds Awards...
WHO cautions against increase of chikungunya illness
MENAFN
·
July 28, 2025
(MENAFN) The World Health Organization (WHO) has warned on Tuesday that without swift measures, the world risks facing a resurgence similar to the 2005 chikungunya outbreak. “Although chikungunya is not widely recognized, it is currently present...
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information
GlobeNewswire, Inc.
·
August 7, 2025
Saint Herblain (France), August 7, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the FDA has removed its recommended pause in the use of IXCHIQ® in individuals 60 years of age and older...
Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ®
GlobeNewswire, Inc.
·
June 5, 2025
IXCHIQ® was well tolerated by children aged one to eleven years regardless of the dose or previous chikungunya infection (CHIKV) Antibody levels remained high after six months in both dose groups, although more robust with the full dose Six-month...
NY Rum Fest & Conference takes place in Brooklyn on June 7th
EIN Presswire
·
May 26, 2025
Celebrating its 9th anniversary, New York Rum Fest continues with its core goal to promote rum education and premiumization. NEW YORK, NY, UNITED STATES, May 26, 2025 /EINPresswire.com/ -- Returning to NYC for its ninth year on Saturday, June...
Combined General Meeting of June 13, 2025
GlobeNewswire, Inc.
·
May 23, 2025
Combined General Meeting of June 13, 2025 Access to information Paris, France – May 23, 2025 – Atos SE shareholders are invited to attend the Combined General Meeting of the Company to be held on Friday, June 13, 2025 at 10 a.m. (Paris time) at...
Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States
GlobeNewswire, Inc.
·
May 12, 2025
Saint Herblain (France), May, 12 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug Association (FDA) and the U.S. Centers for Disease Control and Prevention (CDC), in a...
Combined General Meeting of June 11, 2025
GlobeNewswire, Inc.
·
May 15, 2025
Châtillon, France, May 15, 2025 Combined General Meeting of June 11, 2025 Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market:...
Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly
GlobeNewswire, Inc.
·
May 7, 2025
Saint Herblain (France), May, 07 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) has started a review of Valneva’s single-dose live attenuated chikungunya...
Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers
GlobeNewswire, Inc.
·
April 18, 2025
Saint Herblain (France), April 18, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that during its regular meeting on April 16, the U.S. Centers for Disease Control and Prevention’s (CDC)...
Nüspace Celebrates 20 Years: From a Taxi Garage to a Montreal Design Destination
GlobeNewswire, Inc.
·
April 15, 2025
MONTREAL, April 15, 2025 (GLOBE NEWSWIRE) -- If you had told us back in 2005 that turning an old taxi garage into a design store would be a good idea, we probably would have laughed… and yet, 20 years later, Nüspace is still going strong! What...
Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above
GlobeNewswire, Inc.
·
April 1, 2025
With this extension, IXCHIQ®, the first vaccine against the chikungunya virus (CHIKV), is now available for administration for individuals 12 years of age and older in the European Union (EU). Saint Herblain (France), April 1, 2025 – Valneva SE...
Valneva Submits Adolescent Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to UK MHRA
GlobeNewswire, Inc.
·
March 31, 2025
Saint Herblain (France), March 31, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it has submitted a label extension application to the Medicines and Healthcare products Regulatory Agency...
Unibail-Rodamco-Westfield: Availability of the 2024 Universal Registration Document and terms for holding the Combined General Meeting of Unibail-Rodamco-Westfield SE on April 29, 2025
GlobeNewswire, Inc.
·
March 21, 2025
Paris, March 21, 2025 Press release Availability of the 2024 Universal Registration Document and terms for holding the Combined General Meeting of Unibail-Rodamco-Westfield SE on April 29, 2025 The 2024 Universal Registration Document of...